NO760837L - - Google Patents
Info
- Publication number
- NO760837L NO760837L NO760837A NO760837A NO760837L NO 760837 L NO760837 L NO 760837L NO 760837 A NO760837 A NO 760837A NO 760837 A NO760837 A NO 760837A NO 760837 L NO760837 L NO 760837L
- Authority
- NO
- Norway
- Prior art keywords
- trifluoromethylthio
- compound
- water
- bromo
- mixture
- Prior art date
Links
- 150000001875 compounds Chemical group 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- 239000000203 mixture Substances 0.000 description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- 238000000034 method Methods 0.000 description 9
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 8
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 8
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 239000002253 acid Substances 0.000 description 7
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 7
- 229910052794 bromium Inorganic materials 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 229910052938 sodium sulfate Inorganic materials 0.000 description 6
- 235000011152 sodium sulphate Nutrition 0.000 description 6
- 229960001413 acetanilide Drugs 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 239000003708 ampul Substances 0.000 description 4
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- CAKWJBKQZUOMMF-UHFFFAOYSA-N 1-fluoro-4-nitro-2-(trifluoromethylsulfanyl)benzene Chemical compound [O-][N+](=O)C1=CC=C(F)C(SC(F)(F)F)=C1 CAKWJBKQZUOMMF-UHFFFAOYSA-N 0.000 description 3
- QTBPZZLJAGVEAM-UHFFFAOYSA-N 4-bromo-3-(trifluoromethylsulfanyl)aniline Chemical compound NC1=CC=C(Br)C(SC(F)(F)F)=C1 QTBPZZLJAGVEAM-UHFFFAOYSA-N 0.000 description 3
- OMDVCPVYJUCGHK-UHFFFAOYSA-N 4-fluoro-3-(trifluoromethylsulfanyl)aniline Chemical compound NC1=CC=C(F)C(SC(F)(F)F)=C1 OMDVCPVYJUCGHK-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000000155 melt Substances 0.000 description 3
- -1 monosubstituted piperazine Chemical class 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- TVJNFBMZRGVEOO-UHFFFAOYSA-N 1-bromo-4-nitro-2-(trifluoromethylsulfanyl)benzene Chemical compound [O-][N+](=O)C1=CC=C(Br)C(SC(F)(F)F)=C1 TVJNFBMZRGVEOO-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- FZERHIULMFGESH-UHFFFAOYSA-N N-phenylacetamide Chemical compound CC(=O)NC1=CC=CC=C1 FZERHIULMFGESH-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 230000000578 anorexic effect Effects 0.000 description 2
- 230000002891 anorexigenic effect Effects 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 2
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 2
- 239000012259 ether extract Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 238000001640 fractional crystallisation Methods 0.000 description 2
- 238000001033 granulometry Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000010907 mechanical stirring Methods 0.000 description 2
- 150000002828 nitro derivatives Chemical class 0.000 description 2
- 235000003270 potassium fluoride Nutrition 0.000 description 2
- 239000011698 potassium fluoride Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- DBGIVFWFUFKIQN-UHFFFAOYSA-N (+-)-Fenfluramine Chemical compound CCNC(C)CC1=CC=CC(C(F)(F)F)=C1 DBGIVFWFUFKIQN-UHFFFAOYSA-N 0.000 description 1
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 1
- IWRJVJJQWGZKMT-UHFFFAOYSA-N 1-bromo-2-(trifluoromethylsulfanyl)benzene Chemical compound FC(F)(F)SC1=CC=CC=C1Br IWRJVJJQWGZKMT-UHFFFAOYSA-N 0.000 description 1
- SXEQQBBOAMHOID-UHFFFAOYSA-N 1-bromo-4-nitro-2-(trifluoromethyl)benzene Chemical compound [O-][N+](=O)C1=CC=C(Br)C(C(F)(F)F)=C1 SXEQQBBOAMHOID-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 244000182067 Fraxinus ornus Species 0.000 description 1
- 231100000111 LD50 Toxicity 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- 150000001555 benzenes Chemical class 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000006193 diazotization reaction Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229960001582 fenfluramine Drugs 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- BLNWTAHYTCHDJH-UHFFFAOYSA-O hydroxy(oxo)azanium Chemical compound O[NH+]=O BLNWTAHYTCHDJH-UHFFFAOYSA-O 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008450 motivation Effects 0.000 description 1
- 230000037023 motor activity Effects 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 235000006286 nutrient intake Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000006180 nutrition needs Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 150000004885 piperazines Chemical class 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000006798 ring closing metathesis reaction Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000001119 stannous chloride Substances 0.000 description 1
- 235000011150 stannous chloride Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7507650A FR2303549A1 (fr) | 1975-03-12 | 1975-03-12 | Nouveau derive monosubstitue de piperazine, ses sels, sa preparation et les medicaments qui en renferment |
Publications (1)
Publication Number | Publication Date |
---|---|
NO760837L true NO760837L (fr) | 1976-09-14 |
Family
ID=9152445
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO760837A NO760837L (fr) | 1975-03-12 | 1976-03-10 |
Country Status (19)
Country | Link |
---|---|
US (1) | US4044132A (fr) |
JP (1) | JPS51118779A (fr) |
AT (1) | AT350575B (fr) |
AU (1) | AU497004B2 (fr) |
BE (1) | BE839516A (fr) |
CA (1) | CA1058180A (fr) |
CH (1) | CH608796A5 (fr) |
DE (1) | DE2609574C3 (fr) |
DK (1) | DK139266B (fr) |
ES (1) | ES445969A1 (fr) |
FR (1) | FR2303549A1 (fr) |
GB (1) | GB1503626A (fr) |
GR (1) | GR59892B (fr) |
IE (1) | IE42710B1 (fr) |
LU (1) | LU74548A1 (fr) |
NL (1) | NL7602538A (fr) |
NO (1) | NO760837L (fr) |
SE (1) | SE7602760L (fr) |
ZA (1) | ZA761393B (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4202898A (en) * | 1978-06-05 | 1980-05-13 | Synthelabo | Method of treating anxiety and depression |
DE3772909D1 (de) * | 1986-09-03 | 1991-10-17 | Ciba Geigy Ag | 3-methylphthalimide. |
EP0259264A1 (fr) * | 1986-09-03 | 1988-03-09 | Ciba-Geigy Ag | Méthyl-4 phtalimides |
DE3737985A1 (de) * | 1987-11-09 | 1989-05-18 | Bayer Ag | Am aromatischen kern fluor enthaltende fluormethoxy- und fluormethylthio-aminobenzole und deren herstellung |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3637705A (en) * | 1968-10-01 | 1972-01-25 | Abbott Lab | N-3 4-dihalo phenyl piperazines |
FR2179491B1 (fr) * | 1972-04-10 | 1975-10-10 | Synthelabo |
-
1975
- 1975-03-12 FR FR7507650A patent/FR2303549A1/fr active Granted
-
1976
- 1976-02-27 SE SE7602760A patent/SE7602760L/xx not_active Application Discontinuation
- 1976-03-05 IE IE464/76A patent/IE42710B1/en unknown
- 1976-03-08 ZA ZA761393A patent/ZA761393B/xx unknown
- 1976-03-08 DE DE2609574A patent/DE2609574C3/de not_active Expired
- 1976-03-09 CA CA247,419A patent/CA1058180A/fr not_active Expired
- 1976-03-10 GB GB9617/76A patent/GB1503626A/en not_active Expired
- 1976-03-10 NO NO760837A patent/NO760837L/no unknown
- 1976-03-11 US US05/665,884 patent/US4044132A/en not_active Expired - Lifetime
- 1976-03-11 ES ES445969A patent/ES445969A1/es not_active Expired
- 1976-03-11 DK DK106076AA patent/DK139266B/da unknown
- 1976-03-11 NL NL7602538A patent/NL7602538A/xx not_active Application Discontinuation
- 1976-03-12 JP JP51027623A patent/JPS51118779A/ja active Pending
- 1976-03-12 AU AU11971/76A patent/AU497004B2/en not_active Expired
- 1976-03-12 BE BE165121A patent/BE839516A/fr unknown
- 1976-03-12 CH CH763135A patent/CH608796A5/xx not_active IP Right Cessation
- 1976-03-12 GR GR50289A patent/GR59892B/el unknown
- 1976-03-12 LU LU74548A patent/LU74548A1/xx unknown
- 1976-03-12 AT AT183476A patent/AT350575B/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CH608796A5 (fr) | 1979-01-31 |
JPS51118779A (en) | 1976-10-18 |
AU497004B2 (en) | 1978-11-16 |
GR59892B (en) | 1978-03-15 |
NL7602538A (nl) | 1976-09-14 |
FR2303549A1 (fr) | 1976-10-08 |
SE7602760L (sv) | 1976-09-13 |
DK139266B (da) | 1979-01-22 |
US4044132A (en) | 1977-08-23 |
FR2303549B1 (fr) | 1979-08-10 |
DK139266C (fr) | 1979-06-25 |
ES445969A1 (es) | 1977-05-16 |
BE839516A (fr) | 1976-09-13 |
DK106076A (fr) | 1976-09-13 |
DE2609574A1 (de) | 1976-09-23 |
AU1197176A (en) | 1977-09-15 |
AT350575B (de) | 1979-06-11 |
IE42710L (en) | 1976-09-12 |
ATA183476A (de) | 1978-11-15 |
ZA761393B (en) | 1977-02-23 |
LU74548A1 (fr) | 1976-09-01 |
DE2609574C3 (de) | 1978-06-22 |
GB1503626A (en) | 1978-03-15 |
IE42710B1 (en) | 1980-10-08 |
CA1058180A (fr) | 1979-07-10 |
DE2609574B2 (de) | 1977-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS58174380A (ja) | 新規スコピン誘導体 | |
FR2596049A1 (fr) | Derives de dichloroaniline | |
EP0307303B1 (fr) | [(Pyrimidinyl-2)-aminoalkyl]-1 pipéridines, leur préparation et leur application en thérapeutique | |
FR2735127A1 (fr) | Nouvelles piperazines heteroaromatiques utiles comme medicaments. | |
US4064139A (en) | Substituted 9,10-dihydroanthracen-9,10-imines | |
US3067101A (en) | Method for controlling hypertension | |
CH387636A (fr) | Procédé de préparation de nouvelles phénothiazines | |
EP0677042B1 (fr) | Ligands selectifs des recepteurs 5ht1d-5ht1b derives d'indole-piperazine utiles comme medicaments | |
DE69315085T2 (de) | 1,4-disubstituierte piperazine zur behandlung von asthma und entzündungen der atemwege | |
EP0008645B1 (fr) | Alcoxyphénylpyrrolidones, procédé pour leur préparation et médicaments les contenant | |
NO760837L (fr) | ||
US3557127A (en) | Substituted cyclohexenes,derivatives thereof and processes for obtaining same | |
NO146356B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive alkanolaminderivater | |
EP0062887B1 (fr) | Dérivés de l'indolinone-2, procédé pour leur préparation et médicaments neuroanabolisants les contenant | |
JPS58164570A (ja) | アセメタシンの製造法 | |
JPH0285236A (ja) | プロパンアミン誘導体 | |
GB2040933A (en) | Cis- and Trans-3-Aryloxy-4- Hydroxypyrrolidines and Derivatives Thereof | |
EP0083222B1 (fr) | Acides quinoléinylacétiques et compositions pharmaceutiques les contenant | |
JPH0559117B2 (fr) | ||
EP0520882B1 (fr) | Dérivés de 2-aminopyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique | |
NO124163B (fr) | ||
DE60312511T2 (de) | Oxophenylcyclohexylpropanolaminderivate, deren herstellung und verwendung in therapeutika | |
JPS6296478A (ja) | 新規なイソオキサゾ−ル誘導体 | |
JPS6040420B2 (ja) | 3−アミノ−2−(5−フルオル−及び5−メトキシ−1h−インド−ル−3−イル)プロパン酸誘導体類、その製法及び利用 | |
US3943254A (en) | Beta-adrenergic antagonists |